false --12-31 Q1 0000278165 0000278165 2026-01-01 2026-03-31 0000278165 2026-05-20 0000278165 2026-03-31 0000278165 2025-12-31 0000278165 us-gaap:RelatedPartyMember 2026-03-31 0000278165 us-gaap:RelatedPartyMember 2025-12-31 0000278165 us-gaap:NonrelatedPartyMember 2026-03-31 0000278165 us-gaap:NonrelatedPartyMember 2025-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2026-03-31 0000278165 us-gaap:SeriesAPreferredStockMember 2025-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2026-03-31 0000278165 us-gaap:SeriesBPreferredStockMember 2025-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2026-03-31 0000278165 us-gaap:SeriesCPreferredStockMember 2025-12-31 0000278165 2025-01-01 2025-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-12-31 0000278165 us-gaap:CommonStockMember 2024-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000278165 us-gaap:RetainedEarningsMember 2024-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000278165 2024-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-12-31 0000278165 us-gaap:CommonStockMember 2025-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000278165 us-gaap:RetainedEarningsMember 2025-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0000278165 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000278165 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-03-31 0000278165 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000278165 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-03-31 0000278165 us-gaap:CommonStockMember 2025-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000278165 us-gaap:RetainedEarningsMember 2025-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000278165 2025-03-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2026-03-31 0000278165 us-gaap:CommonStockMember 2026-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000278165 us-gaap:RetainedEarningsMember 2026-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0000278165 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0000278165 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0000278165 us-gaap:WarrantMember 2026-01-01 2026-03-31 0000278165 us-gaap:WarrantMember 2025-01-01 2025-03-31 0000278165 2025-12-01 2025-12-31 0000278165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OMQS:NoCustomerMember 2026-01-01 2026-03-31 0000278165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OMQS:NoCustomerMember 2025-01-01 2025-12-31 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:NoCustomerMember 2026-01-01 2026-03-31 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:NoCustomerMember 2025-01-01 2025-12-31 0000278165 OMQS:TradePayableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2025-01-01 2025-12-31 0000278165 2025-01-01 2025-12-31 0000278165 OMQS:LeumiBankMember 2021-07-29 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2021-07-29 0000278165 OMQS:LeumiBankMember 2021-07-28 2021-07-29 0000278165 OMQS:LeumiBankMember 2025-12-31 0000278165 OMQS:LeumiBankMember 2026-03-31 0000278165 2021-08-11 0000278165 2021-08-10 2021-08-11 0000278165 OMQS:HapoalimBankMember 2023-12-31 0000278165 OMQS:HapoalimBankMember OMQS:IsraeliPrimeRateMember 2023-12-31 0000278165 OMQS:HapoalimBankMember 2026-03-31 0000278165 OMQS:HapoalimBankMember 2025-12-31 0000278165 OMQS:HapoalimBankMember 2024-02-29 0000278165 OMQS:HapoalimBankMember us-gaap:PrimeRateMember 2024-02-29 0000278165 OMQS:HapoalimBankMember 2024-07-31 0000278165 OMQS:HapoalimBankMember us-gaap:PrimeRateMember 2024-07-31 0000278165 OMQS:HapoalimBankMember us-gaap:PrimeRateMember 2025-12-31 0000278165 OMQS:LeumiBankMember 2023-12-31 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2023-12-31 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2025-12-31 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2026-03-31 0000278165 OMQS:LeumiBankMember us-gaap:LongTermDebtMember 2024-03-31 0000278165 OMQS:LeumiBankMember us-gaap:PrimeRateMember 2025-12-31 0000278165 OMQS:LeumiBankMember us-gaap:PrimeRateMember 2026-03-31 0000278165 2025-06-30 0000278165 OMQS:LeumiBankMember 2025-12-31 0000278165 OMQS:LeumiBankMember 2026-03-31 0000278165 OMQS:TzameretMember 2023-09-21 0000278165 OMQS:TzameretMember 2023-09-21 2023-09-21 0000278165 OMQS:TzameretMember 2025-12-31 0000278165 OMQS:TzameretMember 2026-03-31 0000278165 OMQS:PromissoryNoteMember 2026-03-31 0000278165 OMQS:PromissoryNoteMember 2025-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-03-31 0000278165 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-03-31 0000278165 2024-11-03 2024-11-03 0000278165 2025-03-01 2025-03-31 0000278165 2025-06-30 2025-06-30 0000278165 2025-07-11 2025-07-11 0000278165 srt:MaximumMember 2025-07-11 0000278165 2025-07-11 0000278165 srt:MaximumMember 2025-07-11 2025-07-11 0000278165 us-gaap:SeriesOfIndividuallyImmaterialAssetAcquisitionsMember 2025-07-11 2025-07-11 0000278165 OMQS:ShaiLustgartenMember 2025-01-01 2025-12-31 0000278165 OMQS:ShaiLustgartenMember 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure OMQS:Integer iso4217:ILS

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: March 31, 2026

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from________ to__________

 

Commission File Number: 001-40768

 

OMNIQ Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   20-3454263

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1865 West 2100 South

Salt Lake City, UT 84119

(Address of principal executive offices) (Zip Code)

 

(801) 242-7272

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   OMQS   OTCMKTS

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
       
Non-accelerated filer Smaller reporting company
(Do not check if a smaller reporting company)      
       
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 15,152,930 shares of common stock, $0.001 par value, as of May 20, 2026.

 

 

 

 

 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION F-1
ITEM 1. FINANCIAL STATEMENTS F-1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS AT MARCH 31, 2026 AND DECEMBER 31, 2025 F-1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE THREE MONTHS ENDED MARCH 31, 2026, AND 2025 F-2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025 F-3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2026, AND 2025 F-4
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS F-5
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 3
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 5
ITEM 4. CONTROLS AND PROCEDURES 5
PART II - OTHER INFORMATION 7
ITEM 1. LEGAL PROCEEDINGS. 7
ITEM 1A. RISK FACTORS. 7
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. 7
ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 7
ITEM 4. MINE SAFETY DISCLOSURES. 7
ITEM 5. OTHER INFORMATION. 7
ITEM 6. EXHIBITS. 8
SIGNATURES 9

 

2

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

OMNIQ CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31, 2026   December 31, 2025 
(In thousands, except share and per share data)  As of 
   March 31, 2026   December 31, 2025 
   (UNAUDITED)     
ASSETS          
Current assets          
Cash and cash equivalents  $787   $679 
Accounts receivable, net   8,158    9,536 
Inventory, net   3,253    3,409 
Prepaid expenses   1,137    786 
Other current assets   48    52 
Total current assets   13,383    14,462 
           
Property and equipment, net of accumulated depreciation $1,408 and $1,413, respectively   526    528 
Goodwill   3,304    3,336 
Trade name, net of accumulated amortization of $5,371 and _$5,334, respectively   1,084    1,154 
Customer relationships, net of accumulated amortization of $13,587 and $13,474, respectively   2,543    2,757 
Other intangibles, net of accumulated amortization of $2,032 and $2,038, respectively   307    335 
Right of use lease asset   2,487    1,656 
Other assets   1,916    1,948 
Total Assets  $25,550   $26,176 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities          
Accounts payable and accrued liabilities  $10,503   $11,232 
Line of credit   1,940    1,342 
Accrued payroll and sales tax   1,464    1,649 
Related party advances   5,624    3,767 
Note payable – related party, short term   919    919 
Notes payable – current portion   4,621    5,486 
Lease liability – current portion   686    373 
Other current liabilities   2,267    2,933 
Total current liabilities   28,024    27,701 
           
Long-term liabilities          
Related party notes payable   8,491    8,690 
Notes payable, less current portion   883    530 
Lease liability   1,666    1,237 
Other long term liabilities   634    715 
Total liabilities   39,698    38,873 
           
Commitments and Contingencies (See Note 8)          
           
Stockholders’ equity (deficit)          
Series A Preferred stock; $0.001 par value; 2,000,000 shares designated, 0 shares issued and outstanding   -    - 
Series B Preferred stock; $0.001 par value; 1 share designated, 0 shares issued and outstanding   -    - 
Series C Preferred stock; $0.001 par value; 3,000,000 shares designated, 502,000 shares issued and outstanding, respectively   1    1 
Common stock; $0.001 par value; 35,000,000 shares authorized; 15,152,930 and 15,102,930 shares issued and outstanding, respectively.   15    15 
Additional paid-in capital   113,594    113,592 
Accumulated (deficit)   (125,708)   (124,050)
Accumulated other comprehensive (loss)   (2,050)   (2,255)
Total OmniQ stockholders’ equity (deficit)   (14,148)   (12,697)
           
Total liabilities and stockholders’ equity (deficit)  $25,550   $26,176 

 

The accompanying unaudited notes should be read in conjunction with these unaudited condensed consolidated financial statements.

 

F-1
 

 

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

(In thousands, except share and per share data)  2026   2025 
   For the Three months ended 
   March 31 
(In thousands, except share and per share data)  2026   2025 
Revenues  $7,680   $7,979 
           
Cost of goods sold   5,425    5,796 
           
Gross profit   2,255    2,183 
           
Operating expenses          
Research & Development   478    485 
Selling, general and administrative   2,771    1,866 
Depreciation   16    26 
Amortization   256    232 
Total operating expenses   3,521    2,609 
Loss from operations   (1,266)   (426)
           
Other income (expenses):          
Interest expense   (306)   (260)
Other (expenses) income   (79)   (942)
Total other expenses   (385)   (1,202)
Net Loss Before Income Taxes   (1,651)   (1,628)
Current Provision for Income Taxes   -    36 
Total Provision for Income Taxes   -    36 
Net Income (Loss) before discontinued operations   (1,651)   (1,592)
Loss from Discontinued Operations, net   -    (497)
           
Net Loss  $(1,651)  $(2,089)
           
Net Loss  $(1,651)  $(2,089)
Foreign currency translation adjustment   205    491 
Comprehensive loss  $(1,446)  $(1,598)
           
Reconciliation of net loss to net loss attributable to common shareholders          
Net loss  $(1,651)  $(2,089)
Less: Dividends attributable to non-common stockholders’ of OmniQ Corp   (7)   (7)
Net loss attributable to common stockholders’ of OmniQ Corp  $(1,658)  $(2,096)
           
Net (loss) per share - basic attributable to common stockholders’ of OmniQ Corp  $(0.11)  $(0.19)
Net (loss) per share - diluted attributable to common stockholders’ of OmniQ Corp  $(0.11)  $(0.19)
Weighted average number of common shares outstanding – basic and diluted   15,140,705    10,712,930 

 

The accompanying unaudited notes should be read in conjunction with these unaudited condensed consolidated financial statements.

 

F-2
 

 

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

For the Three Months ended March 31, 2025 and 2026

 

(In thousands)  Shares   Amount   Shares   Amount   Capital   Deficit   Income (Loss)   (Deficit) 
   Series C       Additional       Accumulated Other   Total Stockholders’ 
   Preferred Stock   Common Stock   Paid-in   Accumulated   Comprehensive   Equity 
(In thousands)  Shares   Amount   Shares   Amount   Capital   Deficit   Income (Loss)   (Deficit) 
                                 
Balance, December 31, 2024   502   $1    10,712   $11   $78,713   $(123,899)  $1,286   $(43,888)
                                         
Dividend on Class C Shares   -    -    -    -    -    (7)   -    (7)
Stock-based compensation – options, warrants, issuances   -    -    -    -    2    -    -    2 
Cumulative Translation Adjustment   -    -    -    -    -    -    491    491 
Net (loss) income   -    -    -    -    -    (2,089)   -    (2,089)
Balance, March 31, 2025   502   $1    10,712   $11   $78,715   $(125,995)  $1,777   $(45,491)
Balance, December 31, 2025   502   $1    15,102   $15   $113,592   $(124,050)  $(2,255)  $(12,697)
Dividend on Class C Shares   -    -    -    -    -    (7)   -    (7)
Exercise of stock option   -    -    50    -    2    -    -    2 
Stock Based Compensation   -    -    -    -    -    -    -    - 
Cumulative Translation Adjustment   -    -    -    -    -    -    205    205 
Net (loss) income   -    -    -    -    -    (1,651)   -    (1,651)
Balance, March 31, 2026   502   $1    15,152   $15   $113,594   $(125,708)  $(2,050)  $ (14,148)

 

The accompanying unaudited notes should be read in conjunction with these condensed unaudited consolidated financial statements.

 

F-3
 

 

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

For the Three Months Ended March 31,

 

(In thousands)  2026   2025 
Cash flows from operations          
Net loss  $

(1,651

)  $(2,089)
Loss from discontinued operations   -    497 
           
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Stock-based compensation        2 
Depreciation and amortization   291    283 
Amortization of ROU asset   

1

    114 
Loss from sale of other assets   

(249

)   (4)
Changes in operating assets and liabilities:          
Accounts receivable   973    1,572
Prepaid expenses   

(345

)   154)
Inventory   131    353 
Other assets   31    48 
Accounts payable and accrued liabilities   (392)   (1,149)
Accrued payroll and sales taxes payable   (233)   104 
Lease liability   (85)   (116 
Deferred tax assets, net   (3)   (45)
Other liabilities   1,461   (134)
Net cash provided by (used in) operating activities - continuing   

(70

)   (410)
Net cash provided by (used in) operating activities - discontinuing   -    1,428 
Net cash provided by (used in) operating activities   (70)   1,018
Cash flows from investing activities          
Purchase of property and equipment   (26)   (31)
           
Net cash (used in) investing activities – continuing operations   (26)   (31)
Net cash (used in) investing activities – discontinuing operations   -    - 
Net cash (used in) investing activities   (26)   (31)
           
Cash flows from financing activities          
Net proceeds on exercise of options   3    - 
Payments on notes/loans payable   (1,236)   (902)
Proceeds from draw on line of credit   

558

   (223)
Net cash (used in) provided by financing activities – continuing operations   (675)   (1,125)
Net cash (used in) provided by financing activities – discontinuing operations   -    (40)
Net cash (used in) provided by financing activities   (675)   (1,165)
           
Net change in cash and cash equivalents   (771)   (178)
           
Effect of foreign exchange rates on cash and cash equivalents   879    541 
           
Cash and cash equivalents at beginning of period   679    2,349 
           
Cash and cash equivalents at end of period  $787   $2,712
           
Non-cash activities:          
Declared dividends payable  $7   $7
Right of use asset acquired in exchange for lease liability  $-   $-
Supplemental disclosure of cash flow information:          
Cash paid for interest  $

185

   $450
Cash paid for income taxes  $-   $-

 

The accompanying unaudited notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-4
 

 

OMNIQ CORP.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The condensed consolidated financial statements include the accounts of OMNIQ Corp, and its wholly owned subsidiaries, referred to herein as “we,” “us,” “OMNIQ,” or the “Company.” Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”).

 

We describe our significant accounting policies in Note 2 of the notes to consolidated financial statements in the 2025 Form 10-K. During the three-month period ended March 31, 2026, there were no significant changes to those accounting policies other than below.

 

Recent Accounting Pronouncements not yet adopted

 

In November 2024, the FASB issued ASU 2025-03 “Income Statement: Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40)” to improve the disclosures about an entity’s expenses. Upon adoption, we will be required to disclose in the notes to the financial statements a disaggregation of certain expense categories included within the expense captions on the face of the income statement. The standard is effective for our 2027 annual period, and our interim periods beginning in 2028, with early adoption permitted. The standard can be applied either prospectively or retrospectively. We are currently assessing adoption timing and the effect that the updated standard will have on our financial statement disclosures.

 

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The standard changes when capitalization of internal-use software costs begins and updates the related guidance for modern software development methods. The Company is evaluating the impact of this guidance on the timing of capitalization, amortization, and related disclosures. The standard is effective for annual periods beginning after December 15, 2027, including interim periods within those annual periods, with early adoption permitted.

 

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the three-months ended March 31, 2026, and 2025 were15,140,705 and 10,712,930, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:

 

   March 31, 2026   March 31, 2025 
Options to purchase common stock   2,027,833    1,342,833 
Warrants to purchase common stock   6,875,901    759,235 
Potential shares excluded from diluted net loss per share   8,903,734    2,102,068 

 

F-5
 

 

NOTE 2 – GOING CONCERN

 

The accompanying condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. The following are the principal conditions or events which potentially raise substantial doubt about the company’s ability to continue as a going concern:

 

  Balancing the need for operational cash with the need to add additional products.
  Timely and cost-effective development of products
  Working capital deficit of $14.6 million as of March 31, 2026
  Accumulated deficit of $125.7 million as of March 31, 2026
  Multiple years of losses from operations

 

Management Evaluation

 

Management considers the conditions outlined above as the most significant factors in raising substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.

 

Management’s Plans to Mitigate and Alleviate Conditions or Events

 

  Management is evaluating operating expenses and is developing a plan to reduce expenditures without negatively impacting current operations.
  Management has placed a strategic focus on increasing sales with prime customers.
  Sales efforts are focused on the most profitable product lines.
 

The Company has implemented an aggressive debt settlement plan with its vendors and debt holders to clean up the Balance Sheet presentation and during 2025, the Company was able to settle many debts for a discount.

 

Short term liabilities for the Company decreased from $86.3 million to roughly $27.7 million, showing the efforts of management are working.

    In December 2025 management finalized an equity raise which resulted in approximately $941,000 net cash received from investors.

 

NOTE 3 – CONCENTRATIONS

 

For the three-months ended March 31, 2026, and the year ended December 31, 2025, no customer accounted for more than 10% of the Company’s consolidated revenues from continuing operations.

 

Accounts receivable at March 31, 2026 and December 31, 2025 are made up of trade receivables due from customers in the ordinary course of business. No customer accounted for more than 10% of the outstanding receivables as of March 31, 2026, and 11.2% as of December 31, 2025.

 

For the three months ended March 31, 2026, and the year ended December 31, 2025 one vendor made up 45% and 45%, respectively, of our purchases.

 

NOTE 4 – INVENTORY

 

Inventory consisted of the following as of:

 

In thousands  March 31, 2026   December 31, 2025 
         
Raw materials  $248   $283 
Inventory in transit   541    440 
Finished goods (less allowance)   3,231    3,409 
Less allowance for obsolescence   (767)   (723)
Total inventories  $3,253   $3,409 

 

NOTE 5 – RELATED PARTY NOTES PAYABLE

 

Concurrent with the sale of the Quest Solution division, the company entered into a Transition Services Agreement whereas the costs for some employees would be split during the transition. Connected to that was advances to OMNIQ from the Buyer to facilitate the transition. This entity is majority controlled by the Company’s CEO and thus treated as related party advances. The balance as of December 31, 2025 was $3,767,032 and at March 31, 2026 was $5,624,040. This is non interest bearing with no predefined or agreed upon repayment term.

 

F-6
 

 

In addition and concurrent with the sale of the Quest Solution division, the Company entered into a Promissory Note which bears interest at 5% per annum, is amortized over a ten-year period, and provides for a balloon payment after the third year. The balance at December 31, 2025 was $9.6 million and at March 31, 2026 was $9.4 million.

 

NOTE 6 – OTHER NOTES PAYABLE

 

(In thousands)  March 31, 2026   December 31, 2025 
Note payable other   5,504    6,016 
Less current portion   (4,621)   (5,486)
Long-term notes payable  $883   $530 

 

In thousands  March 31, 2026   December 31, 2025 
Related Party Notes Payable - other  $9,410   $9,609 
Less current portion of related party note payable   (919)   (919) 
Long Term Notes Payable – related party  $8,491   $8,690 

 

Notes Payable Other

 

On July 29, 2021, the Company entered into a long-term loan from Leumi Bank totaling NIS 7 million, which at the time was approximately $2.16 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd At December 31, 2025, the balance owed is $437,500 USD and at March 31, 2026, the balance owed is $385,000 USD.

 

On August 11, 2021, the Company purchased vehicles using cash and financing of NIS 500 thousand, approximately $155 thousand, to be paid off in monthly interest and principal payments over 5 years. The loan accrues interest at 7.5% per annum and is secured by the vehicles. This was completed in January 2025.

 

During the year ended December 31, 2023, the Company entered into a short-term loan Hapoalim Bank totaling NIS 5.5 million, approximately US $1.5 million. The note accrues interest at 7.3% per annum. The loan is renewed every month at Israeli Prime Rate plus + 1.3%, which at March 31, 2026 was 7.3% and at December 31, 2025 was 7.05%.

 

In February 2024, NIS 1.5 million of the loan was converted into a short-term loan to be repaid in 12 installments, bearing interest at Prime + 1.5%.

 

In July 2024, an additional 1.5 million was converted into a long-term loan to be repaid in 18 installments, bearing interest at a rate of Prime + 1.5%.

 

In December 2025, an additional 0.8 million was converted into a long-term loan to be repaid in 12 installments, bearing interest at a rate of Prime + 2.2%, the balance at December 31, 2025 was still $0.8 million and at March 31, 2026 was $0.6 million.

 

At December 31, 2025, the Company owed Hapoalim Bank USD $1.39 million. At March 31, 2026, the balance was approximately $1.12 million.

 

During the year ended December 31, 2023, the Company entered into a short-term loan from Bank Leumi totaling NIS 21.5 million, approximately US $5.9 million. The note accrues interest at 7.6% per annum. The loan is renewed every month at Israeli Prime Rate plus 1.89%, which at December 31, 2025 was 7.64% and at March 31, 2026 was 7.64%.

 

In March 2024, NIS 7.5 million of the loan was converted into a long-term loan to be repaid in 36 installments, bearing interest at a rate of Prime + 3.25%, which at December 31, 2025 was 9.0% which at March 31, 2026 was 9.0%.

 

In June 2025 the Company decreased the balance of the revolving loan by further NIS 4 million.

 

F-7
 

 

The short-term loan (renewed every month) at 2025 is NIS 10 million, approximately US $3.138 million.

 

At December 31, 2025, the Company owed Bank Leumi USD $4.138 million. At March 31, 2026, the Company owed Bank Leumi approximately USD $4 million.

 

On September 21, 2023, the Company entered into a long-term loan from Tzameret Mimunim totaling 1.5M NIS, approximately US $393 thousand. The note accrues interest at the Israeli Prime Rate plus 3.5% which currently equals 9.25% per annum and is payable in 36 monthly installments. The balance at December 31, 2025 is $130 thousand and at March 31, 2026 was $100 thousand.

 

As of March 31, 2026, the Company was not in compliance with certain financial covenants related to the Bank Leumi and Bank Hapoalim debt. The Company’s failure to comply with these financial covenants could result in an event of default under its debt agreements. Therefore, we reclassified the total balance as current debt on the balance sheet. On December 29, 2025, a new covenants agreement was signed with Bank Hapoalim, pursuant to which the Company is required to comply with the financial covenants set forth in the new agreement, commencing with the 2026 financial statements.

 

As part of the sale of the Quest division and its assets, the Company entered into a Promissory Note which bears interest at 5% per annum, is amortized over a ten-year period, and provides for a balloon payment after the third year. The balance at March 31, 2026 was $9.4 million. Due to the related party nature of the CEO of OMNIQ relationship with the Note Holder, this note is deemed related party.

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

PREFERRED STOCK

 

Series A

 

As of March 31, 2026, there were 2,000,000 Series A preferred shares designated and no Series A preferred shares outstanding. The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 13 common shares.

 

Series B

 

As of March 31, 2026, there was 1 preferred share designated and no preferred shares outstanding.

 

Series C

 

As of March 31, 2026, there were 3,000,000 Series C Preferred Shares (“Series C”) authorized with 502,000 issued and outstanding. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $0.06 per share per annum and have a liquidation preference of $1 per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of March 31, 2026, the accrued dividends on the Series C Preferred Stock was $233 thousand.

 

The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.

 

During the quarter ended March 31, 2026, the Company issued 50,000 shares upon exercise and receipt of funds for stock options. The proceeds received were $3,000.

 

F-8
 

 

NOTE 8 – LITIGATION

 

On November 3, 2024 a commercial real estate company filed a lawsuit against Dangot Computers, OMNIQ Technologies and some of Dangot’s officers alleging breach of a letter of intent for a lease arrangement. The claims were brought in an Israeli court. The initial claim against Dangot Computers is NIS 21 million approximately US $5.6 million. The Company believes that it has meritorious defenses to such action and intends to vigorously defend itself. At this early stage, it is not possible to fully assess the chances of a lawsuit. The judge has referred the matter to mediation and the company believes that its exposure is significantly lower than the original claim. The Company has recorded a low level accrual representing the amount it currently estimates will be required for payment.

 

In March 2025, the Company was named a defendant in a case involving a consultant who was terminated and who claims he is owed approximately $389,000 in unpaid fees and commissions. The Company believes it has multiple defense and cross claims against the former consultant and is evaluating its response to the lawsuit, but plans to vigorously defend the suit.

 

On June 30, 2025, the Company’s subsidiary Dangot Computers reached at settlement with one of its vendors in Israel related to past due rebates and price protection payments entitled under prior agreements. The vendor agreed to pay Dangot Computers, approximately USD $1.2 million, based on certain milestones related to additional purchases. These payments are being treated as reduction in Cost of Goods sold upon receipt from the Vendor. As of December 31, 2025, the full amount had been received from the vendor.

 

During 2025, several companies filed third-party and fourth-party claims against our subsidiary, Dangot Computers alleging patent infringement. In the opinion of Dangot’s legal counsel, at this preliminary stage it is not yet possible to assess the likelihood of the claims; therefore, no provision has been recorded in the Company’s financial statements in connection with this matter.

 

NOTE 9 – BUSINESS SEGMENT

 

The Company operates in a single reportable segment, referred to as providing solutions including hardware, software, communications, and automated management service as an established distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources and evaluating financial performance. The accounting policies of our single reportable segment are the same as those for the Company as a whole.

 

NOTE 10 – DISCONTINUED OPERATIONS

 

As discussed in the Form 10K filed April 15, 2026, and the relevant Form 8-K, on July 11, 2025, OMNIQ Corp., a Delaware corporation (the “Company”), together with its subsidiaries, Quest Marketing, Inc., HTS Image Processing, Inc., OmniQ Vision Inc., HTS Image Ltd., OmniQ Technologies Ltd., and Dangot Computers, Ltd. (collectively, the “Sellers”), entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Summit Junction Holdings LLC, a Delaware limited liability company (the “Buyer”).

 

Pursuant to the Purchase Agreement, the Sellers agreed to sell, and Buyer agreed to purchase, substantially all of the assets and assume certain liabilities mainly associated with the Company’s legacy business line, including its integrated hardware, software, and automation solutions business, (the “Transferred Business”). The Transaction was consummated on July 11, 2025. Although the Purchase Agreement is dated as of June 30, 2025, the parties executed the agreement and consummated the Transaction on July 11, 2025.

 

The aggregate consideration for the Transaction is approximately $45.0 million, consisting of the assumption by Buyer of up to $55.0 million in specified liabilities of the Transferred Business and the issuance by the Company of a Promissory Note in the principal amount of $10.0 million in favor of the Buyer. The Promissory Note bears interest at 5% per annum, is amortized over a ten-year period, and provides for a balloon payment after the third year. In addition, the Company is entitled to a contingent payment of up to $10.0 million in the event that, within 18 months following the closing, Buyer either (i) consummates a sale of all or substantially all of its assets or equity for consideration in excess of $100.0 million or (ii) completes an initial public offering at a valuation exceeding $100.0 million.

 

The assets sold include, among other things, accounts receivable, inventory, tangible personal property, intellectual property, contract rights, books and records, and other assets used or held for use in connection with the Transferred Business. Certain assets were excluded from the Transaction, including the Company’s cash and cash equivalents and all assets not related to the Transferred Business. Buyer assumed only those liabilities specified in the Purchase Agreement, and the Company retained all other liabilities, including those unrelated to the Transferred Business or expressly excluded.

 

The Purchase Agreement contains customary representations, warranties, and covenants, including pre-closing operating covenants, post-closing indemnification provisions, and certain limitations on liability. The Transaction and Purchase Agreement were approved by the Company’s Board of Directors effective June 30, 2025 following completion of a fairness opinion, dated June 27, 2025, from an independent financial advisor.

 

In connection with the closing, the Company and Buyer entered into and delivered various ancillary agreements, including a Bill of Sale, Assignment and Assumption Agreement, Trademark Assignment Agreement, Promissory Note, Intellectual Property License Agreement, and Transition Services Agreement. The Company also entered into a consent agreement with its largest vendor Bluestar to consent to the transfer of the liabilities owed to it from the Company to the Buyer. Due to an entity affiliated with Shai Lustgarten, the Company’s CEO as a principal member of the Buyer, the transaction is deemed related party.

 

Pursuant to his employment contract, the CEO, Shai Lustgarten is entitled to a bonus equal to 4% of a total transaction price and pursuant to that, the Board of Directors awarded a bonus of $1.72 million to Mr. Lustgarten.

 

Based on ASC 850-10, ASC 845-10, ASC 820, and SEC Staff Accounting Bulletin Topics 5.G, 5.T, and 1.B.1, the transaction represents a capital contribution from the CEO to the Company. While a fairness opinion was obtained, it does not fully satisfy ASC 820 fair value measurement requirements for full recognition. Accordingly, the $34 million gain is recorded directly to equity as a capital contribution. This conclusion aligns with both the letter and the spirit of applicable GAAP and SEC guidance.

 

The sale resulted in a net gain on disposal of approximately $33.8 million, net of tax, which reflects the difference between the carrying amount of the net assets disposed of and the consideration transferred/assumed, including the promissory note and transaction costs. However, due to the related-party nature of the transaction, management determined to record the gain to Additional Paid-in Capital.

 

F-9
 

 

The net gain (APIC) was calculated as follows (in thousands):

 

     
Reduction of cash and cash equivalents  $(2,388)
Reduction of accounts receivable, net   (4,730)
Reduction of inventory, net   (282)
Reduction of other current assets   (996)
Reduction in property and equipment, net of accumulated depreciation   (48)
Reduction in accounts payable and accrued liabilities   55,000 
Increase in other current liabilities   (1,808)
Increase in related party notes payable   (10,000)
Increase in additional paid-in capital  $(34,748)
      
Income Taxes Payable on transaction  $960 
Additional paid-in capital reduction  $960 

 

Details of net loss from discontinued operations, net of taxes, are as follows (in thousands):

 

For the three months ended  March 31, 2026   March 31, 2025 
Revenues  $    -   $11,924 
Cost of goods sold   -    8,966 
Selling, general and administrative   -    3,198 
Research & Development   -    22 
Depreciation   -    3 
Amortization   -    - 
Interest expense   -    202 
Other expenses (income)   -    30 
Current tax   -    - 
Net Income (Loss) from Discontinued Ops (Net of Tax)  $-   $(497)

 

Because the transaction was effective June 30, 2025, no assets or liabilities disposed in the sale were included on the balance sheet as of December 31, 2025. The balances of the disposed assets and liabilities as of December 31, 2024 were as follows:

 

Assets     
Current Assets     
Accounts receivable, net  $10,608 
Inventory, net   4,197 
Prepaid expenses   482 
Other current assets   61 
Total current assets   15,348 
      
Property and equipment, net of accumulated depreciation   8 
Right of use lease asset   471 
Total Assets  $15,827 
      
LIABILITIES AND STOCKHOLDERS’ EQUITY     
Current liabilities     
Accounts payable and accrued liabilities  $56,863 
Accrued payroll and sales tax   1,490 
Lease liability – current portion   103 
Other current liabilities   206 
Total Current Liabilities   58,662 
Deferred revenue   5,891 
Lease liability   178 
Total liabilities  $64,731 

 

Cash flows related to the discontinued business have not been segregated and are included in the condensed consolidated statements of cash flows. The following table provides supplemental cash-flow information for the discontinued operations (in thousands):

 

   Three months ended
March 31, 2026
   Three months ended
March 31, 2025
 
Depreciation and amortization   -    3 
Capital expenditures   -    106 
Other significant non-cash items          
Cancelation of lease   -    - 

 

NOTE 11 – SUBSEQUENT EVENTS

 

Subsequent Event – Planned Divestiture of CodeBlocks

 

In connection with a transaction executed on June 30, 2025, the Company agreed to divest its CodeBlocks business, which is currently included within goodwill. As of December 31, 2025, the definitive agreements related to the divestiture of CodeBlocks had not been finalized or executed and remained subject to completion of final terms and approvals. Accordingly, the Company concluded that the criteria for classification as held for sale were not met as of year-end.

 

Subsequent to December 31, 2025, the Company has continued to finalize the terms of the transaction, and the definitive agreements are expected to be executed in the near term. The completion of the divestiture remains subject to final execution and customary conditions.

 

As discussed in Note 6. the Dangot Computers subsidiary has a bank loan which as discussed is in negotiations with receiving an extension on the bank covenants.

 

As of May 20, 2026, there are no other material subsequent events that have occurred.

 

F-10
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

PRELIMINARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by, or that include the words “may”, “could”, “would”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate”, “target”, “project”, “intend”, “foresee” and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement the strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs, and sources of liquidity. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

 

Forward-looking statements are only predictions and are not guarantees of performance. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the expansion of product offerings geographically or through new marketing applications, the timing and cost of planned capital expenditures, competitive conditions, and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. In addition, even if our actual results are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, those results may not be indicative of results or developments in subsequent periods. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

 

  Our ability to raise capital when needed and on acceptable terms and conditions;
     
  Our ability to manage credit and debt structures from vendors, debt holders, and secured lenders.
     
  Our ability to manage the growth of our business through internal growth and acquisitions;
     
  Competitive pressures;
     
  Our ability to attract and retain management, and to integrate and maintain technical information and management information systems.
     
  Compliance with laws and regulations, including those relating to environmental matters, corporate governance matters and tax matters, as well as any future changes to such laws and regulations; and

 

For a more detailed discussion of some of the foregoing risks and uncertainties, see Item 1A — “Risk Factors” in our 2025 Form 10-K and Item 1A — “Risk Factors” in this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, as well as other reports and registration statements filed by us with the SEC. These factors should not be construed as exhaustive and should be read with other cautionary statements in this Quarterly Report on Form 10-Q and our other public filings. For more information about us and the announcements we make from time to time, visit our website at www.omniq.com.

 

Introduction

 

From 2008 to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for us.

 

Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine-vision image-processing solutions:

 

  Quest Solutions, Inc. (January 2014)
  Bar Code Specialties, Inc. (November 2014)
  HTS Image Processing, Inc. (October 2018)
  EyepaxIT Consulting LLC. (February 2020)
  Dangot Computers Ltd. (July 2021)

 

We use patented and proprietary artificial intelligence (AI) technology to deliver machine vision image processing solutions including data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management, and access control applications.

 

3
 

 

The technology and services we provide help our clients move people, assets, and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

Our principal solutions include hardware, software, communications, and automated management services, technical service and support. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers. We deliver practical problem-solving solutions backed by numerous customer references.

 

Our customers include government agencies, healthcare, universities, airports, municipalities and more. We currently engage with several billion-dollar markets with double-digit growth, including the Global Safe City market and the Ticketless Safe Parking market.

 

The following is a discussion of our financial condition, results of operations, financial resources, and working capital. This discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements contained in this Form 10-Q.

 

OVERVIEW

 

The Company’s sales from operations for the three months ended March 31, 2026, were $7.7 million, a decrease of approximately $299 thousand or 4%, over the three months ended March 31, 2025.

 

The loss from operations for the three months ended March 31, 2026, was $1.26 million, an increase of $841 thousand compared with the loss in the three months ended March 31, 2025, of $425 thousand. Basic loss per share from continuing operations for the three months ended March 31, 2026, was ($0.13) versus ($0.19) per share for the same period in 2025. Comprehensive loss for the three months ended March 31, 2026 and 2025 was $1.7 million and $1.6 million respectively, the only component to comprehensive loss besides net loss is foreign currency translation.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of March 31, 2026, the Company had cash in the amount of $787 thousand and a working capital deficit of $14.6 million, compared to cash in the amount of $679 thousand, and a working capital deficit of $13.2 million as of December 31, 2025. The Company had stockholders’ deficit attributable to OmniQ stockholders of $14.1 million and $12.7 million as of March 31, 2026, and December 31, 2025, respectively. This increase in our stockholders’ deficit was primarily attributable to net losses.

 

The Company’s accumulated deficit was $125.7 million and $124 million as of March 31, 2026, and December 31, 2025.

 

The Company’s operations provided (used) net cash of $70 thousand and provided $1 million in the three months ended March 31, 2026, and 2025, respectively. The decrease in cash provided in operations of $1 million is due to the decrease in revenue.

 

The Company’s cash used in investing activities was $26 thousand for the three months ended March 31, 2026, compared to cash used in investing activities of $31 thousand for the three months ended March 31, 2025.

 

The Company’s financing activities used $0.68 million of cash during the three months ended March 31, 2026, and used $1.2 million during the three months ended March 31, 2025.

 

Results of Operations

 

The following tables set forth certain selected unaudited condensed consolidated statements of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

 

    For the Three months ended
March 31,
    Variation  
In thousands   2026     2025     $     %  
Revenue   $ 7,680     $ 7,979     $ (299 )     (3.75 )%
Cost of Goods sold     5,425       5,796       (371 )     (6.40 )%
Gross Profit     2,255       2,183       72       3.30 %
Operating Expenses     3,521       2,609       912       34.98 %
Loss from operations     (1,266 )     (426 )     (840 )     197.95 %
Net loss     (1,651 )     (2,089 )     438     (20.95 )%
Net Loss per common Share from continuing operations   $ (0.11 )   $ (0.19 )   $ 0.08       (41.03 )%

 

4
 

 

Revenues

 

For the three months ended March 31, 2026, and 2025, the Company generated net revenues in the amount of $7.7 million and $7.9 million, respectively. The decrease between the three-month periods was attributable to timing of projects by customers.

 

Cost of Goods Sold

 

For the three months ended March 31, 2026, and 2025, the Company recognized a total of $5.4 million and $5.8 million, respectively, of cost of goods sold. For the three months ended March 31, 2026, and 2025, cost of goods sold were 70% and 73% of net revenues, respectively.

 

Operating expenses

 

Total operating expenses for the three months ended March 31, 2026, and 2025 recognized was $3.5 million and $2.6 million, respectively, representing a 35% increase. The increase in operating expenses was due primarily to increase costs in selling and general administrative expenses, specifically salaries.

 

Research and Development – Research and development expenses for the three months ended March 31, 2026, and 2025 totaled $478 thousand and $485 thousand, respectively.

 

Selling, general and Administrative – Selling, general and administrative expenses for the three months ended March 31, 2026, and 2025 totaled $2.7 million and $1.9 million, respectively, representing a 48% increase. The increase was due primarily to increased costs for selling and general administrative expenses.

 

Depreciation – Depreciation expenses for the three months ended March 31, 2026, and 2025 totaled $16 thousand and $26 thousand, respectively, representing a 38% decrease. The decrease is directly related to the reduction in fixed assets.

 

Intangible amortization – Intangible amortization expenses for the three months ended March 31, 2026, and 2025 totaled $256 thousand and $232 thousand, respectively. The increase is due to life of intangibles and what is remaining to be amortized.

 

Other income and expenses

 

Interest Expense – Interest expense for the three months ended March 31, 2026, totaled $306 thousand, as compared to $260 thousand for the three months ended March 31, 2025. The increase is primarily attributable to the line of credit.

 

Inflation

 

The Company’s results of operations have not been materially affected by inflation and management does not expect inflation to have a material impact on its operations in the future.

 

Off- Balance Sheet Arrangements

 

The Company currently does not have any off-balance sheet arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not Applicable

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

(a) Evaluation of Disclosure and Control Procedures

 

We maintain “disclosure controls and procedures”, as such terms are defined under Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosures. The Company acknowledges that any controls and procedures can provide only reasonable assurances of achieving the desired control objectives.

 

5
 

 

We have carried out an evaluation as required by Rule 13a-15(d) under the supervision of and with the participation of our management, including our Chief Executive Officer and Principal Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. Based upon their evaluation, the Chief Executive Officer and Principal Accounting Officer concluded that, as of March 31, 2026, the Company’s disclosure controls and procedures were not effective. Although we have determined that the existing controls and procedures are not effective, the deficiencies identified have not been deemed material to our reporting disclosures.

 

(b) Management’s Report on Internal Controls over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Principal Accounting Officer, and affected by our Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

Internal control over financial reporting cannot provide absolute assurance of achieving their objectives. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgement and breakdowns resulting from human failures. Due to their inherent limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. It is possible to design safeguards to reduce, but not eliminate, this risk. Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.

 

Management has used the framework set forth in the report entitled Internal Control—Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), known as COSO, to evaluate the effectiveness of our internal control over financial reporting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Based on such an evaluation, our CEO concluded that, as of March 31, 2026, our internal controls over financial reporting were not effective.

 

As a result of our evaluation, we identified a material weakness in our controls related to segregation of duties and other immaterial weaknesses in several areas of data management and documentation.

 

Our management is composed of a small number of professionals resulting in a situation where limitations on segregation of duties exist. Accordingly, and as a result of the material weakness identified above, we have concluded that the control deficiencies result in a reasonable possibility that a material misstatement of the annual or interim financial statements may not be prevented on a timely basis by the Company’s internal controls. We continue to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by executives. In addition, we evaluate and assess our internal controls and procedures regarding our financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary on an on-going basis.

 

While the material weakness set forth above was the result of the scale of the Company’s operations and is intrinsic to its small size, the Company believes the risk of material misstatements relative to financial reporting are minimal.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by its registered public accounting firm pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, which permits the Company to provide only management’s report in this annual report.

 

(c) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

6
 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On November 3, 2024 a commercial real estate company filed a lawsuit against Dangot Computers, OMNIQ Technologies and some of Dangot’s officers alleging breach of a letter of intent for a lease arrangement. The claims were brought in an Israeli court. The initial claim against Dangot Computers is NIS 21 million approximately US $5.6 million. The Company believes that it has meritorious defenses to such action and intends to vigorously defend itself. At this early stage, it is not possible to fully assess the chances of a lawsuit. The judge has referred the matter to mediation and the company believes that its exposure is significantly lower than the original claim. The Company has recorded a low level accrual representing the amount it currently estimates will be required for payment.

 

In March 2025, the Company was named a defendant in a case involving a consultant who was terminated and who claims he is owed approximately $389,000 in unpaid fees and commissions. The Company believes it has multiple defense and cross claims against the former consultant and is evaluating its response to the lawsuit, but plans to vigorously defend the suit.

 

On June 30, 2025, the Company’s subsidiary Dangot Computers reached at settlement with one of its vendors in Israel related to past due rebates and price protection payments entitled under prior agreements. The vendor agreed to pay Dangot Computers, approximately USD $1.2 million, based on certain milestones related to additional purchases. These payments are being treated as reduction in Cost of Goods sold upon receipt from the Vendor. As of December 31, 2025, the full amount had been received from the vendor.

 

During 2025, several companies filed third-party and fourth-party claims against our subsidiary, Dangot Computers alleging patent infringement. In the opinion of Dangot’s legal counsel, at this preliminary stage it is not yet possible to assess the likelihood of the claims; therefore, no provision has been recorded in the Company’s financial statements in connection with this matter.

 

ITEM 1A. RISK FACTORS

 

Not applicable.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

 

We have filed with the Securities and Exchange Commission this Form 10-Q, including exhibits. You may read and copy all or any portion of the registration statement or any reports, statements, or other information in the files at SEC’s Public Reference Room located at 100 F Street, NE., Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m.

 

You can request copies of these documents upon payment of a duplicating fee by writing to the Commission. You may call the Commission at 1-800-SEC-0330 for further information on the operation of its public reference room. Our filings, including the registration statement, will also be available to you on the website maintained by the Commission at http://www.sec.gov.

 

We intend to furnish our stockholders with annual reports which will be filed electronically with the SEC containing the consolidated financial statements audited by our independent auditors, and to make available to our stockholder’s quarterly reports for the first three quarters of each year containing unaudited interim consolidated financial statements.

 

Our website is located at http://www.omniq.com. The Company’s website and the information contained on that site, or connected to that site, is not part of or incorporated by reference into this filing.

 

7
 

 

ITEM 6. EXHIBITS

 

EXHIBIT INDEX

 

10.1   Share purchase Agreement dated May 3, 2021, by and between OMNIQ Corp, OMNIQ Technologies Ltd. and Haim Dangot. (incorporated by reference to the Current Report on Form 8-k filed with the SEC on May 6, 2021)
     
31.1   Certification of our Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of our Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of our Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

 

101.INS   Inline XBRL Instance Document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

8
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 20, 2026

 

OMNIQ CORP.  
     
By: /s/ Shai Lustgarten  
  Shai Lustgarten  
  Chief Executive Officer, Interim Chief Financial Officer and Chairman of the Board  

 

9